| scholarly article | Q13442814 |
| P953 | full work available at URL | http://intl-jpet.aspetjournals.org/cgi/content/abstract/217/2/451 |
| P698 | PubMed publication ID | 6262485 |
| P2093 | author name string | E. T. Iwamoto | |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| opioid | Q427523 | ||
| P304 | page(s) | 451-460 | |
| P577 | publication date | 1981-05-01 | |
| P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| P1476 | title | Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists | |
| P478 | volume | 217 |
| Q37033988 | (+)-Morphine and (-)-morphine stereoselectively attenuate the (-)-morphine-produced tail-flick inhibition via the naloxone-sensitive sigma receptor in the ventral periaqueductal gray of the rat. |
| Q24628835 | 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs |
| Q41741664 | A microiontophoretic study of the actions of μ-, δ- and κ-opiate receptor agonists in the rat brain |
| Q37200551 | Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice |
| Q72319565 | Acute effects of sigma ligands on the extracellular DOPAC level in rat frontal cortex and striatum |
| Q36032904 | Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal |
| Q70511992 | An assessment of the spontaneous activity of rats administered morphine, phencyclidine, or nicotine using automated and observational methods |
| Q44340012 | Behavioural effects of selective mu-, kappa-, and delta-opioid agonists in neonatal rats |
| Q28354201 | Blockade of Serotonin 5-HT2A Receptors Suppresses Behavioral Sensitization and Naloxone-Precipitated Withdrawal Symptoms in Morphine-Treated Mice |
| Q44348321 | Comparison of the pharmacologic effects of N-allylnormetazocine and phencyclidine: sensitization, cross-sensitization, and opioid antagonist activity |
| Q46171960 | Differential effects of SKF 10,047 (N-allyl-normetazocine) on peristalsis and longitudinal muscle contractions of the isolated guinea-pig ileum |
| Q48163132 | Distribution of opiate receptors within visual structures of the cat brain |
| Q67486202 | Effects of [D-Ala2, D-Leu5]enkephalin and [D-Pen2, L-Pen5]enkephalin on apomorphine-induced motor activity in the mouse |
| Q52243340 | Effects of morphine, ethylketocyclazocine, N-allylnormetazocine and naloxone on locomotor activity in the rabbit. |
| Q52277875 | Effects of phencyclidine, haloperidol, and naloxone on fixed-interval performance in rats. |
| Q40134061 | Endogenous opiates: 1981 |
| Q52263987 | Evidence for multiple opiate receptor involvement in different phencyclidine-induced unconditioned behaviors in rats. |
| Q42200215 | Expression of morphine-conditioned hyperactivity is attenuated by naloxone and pimozide |
| Q33568277 | Identification of the binding subunit of the sigma-type opiate receptor by photoaffinity labeling with 1-(4-azido-2-methyl[6-3H]phenyl)-3-(2-methyl[4,6-3H]phenyl)guanidine |
| Q69350003 | Inhibitory effect of a selective kappa receptor agonist, U-50, 488H, on methamphetamine-elicited ipsilateral circling behavior in rats with unilateral nigral lesions |
| Q71474942 | Interval-dependent inhibition of morphine sensitization of ambulation in mice by post-morphine treatment with naloxone or restraint |
| Q70171170 | Involvement of both opiate and catecholaminergic receptors of ventromedial hypothalamus in the locomotor stimulant action of thyrotropin-releasing hormone |
| Q39680665 | Juxtaposition of the steroid binding domain-like I and II regions constitutes a ligand binding site in the sigma-1 receptor |
| Q70177349 | Multi-dimensional analyses of behavior in mice treated with morphine, endorphins and [des-tyrosine1]-γ-endorphin |
| Q40139811 | New and experimental therapeutic roles for naloxone and related opioid antagonists |
| Q34253783 | Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat |
| Q28294148 | Novel sigma (sigma) receptor agonists produce antidepressant-like effects in mice |
| Q44345091 | Observational analysis of the effects of kappa opioid agonists an open field behaviour in the rat. |
| Q38004941 | Opioid system and Alzheimer's disease |
| Q48697288 | Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: Comparisons to other psychomotor stimulants |
| Q24608102 | Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine |
| Q48633780 | Sigma 1 receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain |
| Q28266963 | Sigma receptors: biology and therapeutic potential |
| Q46828051 | Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs |
| Q44350685 | Specific opioid-amphetamine interactions in the caudate putamen |
| Q33890721 | The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse |
| Q35856904 | The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements |
Search more.